www.foxbusiness.com

www.foxbusiness.com
Share

www.foxbusiness.com

 •  February 11

WASHINGTON – President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. Those ideas would represent tangible change and they have a realistic chance of being enacted. But it's not like calling for...

www.foxbusiness.com

 •  January 18

MONTPELIER, Vt. – The Vermont Senate is considering a proposal to save money on prescription drugs by importing them from Canada, where many are sold for a fraction of the cost in the United States. The cost of prescription drugs is a factor driving the increase in state health care costs and the state budget, said Democratic and Progressive Sen....

www.foxbusiness.com

 •  January 8

Mylan CEO Heather Bresch said on Tuesday putting the EpiPen price gouging controversy behind has allowed the company to focus on launching generic versions of drugs. The company reached a $465 million settlement with the U.S. Justice Department in August to resolve claims that the company overcharged the government for its EpiPen emergency allergy...

www.foxbusiness.com

 •  January 8

Efforts to find treatments for Alzheimer's disease suffered blows in recent days, but many companies, scientists and investors are still optimistic that they can find a way to treat the memory-robbing disease, which affects roughly 5.5 million Americans. Axovant Sciences Ltd. on Monday shuttered development for a once-promising Alzheimer's drug, an...

www.foxbusiness.com

 •  October 1, 2017

Americans spent $457 billion on prescription drugs in 2015, according to a recent issue of the AARP Bulletin. The most popular brand-name drugs rose 208 percent between 2008 and 2016—bad news for retirees living on a fixed income, and according to one senior citizens lobbying group, because Medicare doesn’t have the authority to negotiate drug...

www.foxbusiness.com

 •  September 7, 2017

New Mexico sued several major pharmaceutical companies and wholesale drug distributors on Thursday, arguing the corporations are partly to blame for rampant opioid addiction rates in the state. The lawsuit, filed in state court in Santa Fe County, follows the lead of half a dozen other states that have also sued over the opioid crisis. All claim...

www.foxbusiness.com

 •  September 7, 2017

INDIANAPOLIS – Eli Lilly will slash its global workforce by nearly 9 percent as the drugmaker closes some research sites and pushes to trim fixed costs. The Indianapolis company said Thursday it will cut about 3,500 positions, mostly through a voluntary retirement program in the United States. The insulin and cancer treatment maker employed 41,240...

www.foxbusiness.com

 •  August 14, 2017

Roche Holding AG shares jumped 6.5% on a single day in early March when the drugmaker said its new breast-cancer treatment, Perjeta, helped prolong average patient survival in a clinical study. But the stock gave up nearly all those gains three months later, when the Swiss company disclosed full details of the trial at a medical conference. The...

www.foxbusiness.com

 •  August 11, 2017

A branded HIV drug that's been shown to reduce the risk of infection with the virus by 86% is proving too expensive for some at-risk European patients. England's National Health Service thinks it has a solution. The high price of Gilead Sciences Inc.'s HIV drug Truvada has deterred many countries from providing the pill as a preventive treatment...

www.foxbusiness.com

 •  August 9, 2017

NEW YORK – Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory environment." Shares tumbled 5 percent and were trading close to four-year lows at the opening bell Wednesday. The...